New guideline on treatment of idiopathic pulmonary fibrosis

Lancet Respir Med. 2015 Sep;3(9):e31-e32. doi: 10.1016/S2213-2600(15)00322-7.

Authors

Paolo Spagnolo¹, Francesco Bonella², Toby M Maher³

Affiliations

¹ Medical University Clinic, Canton Hospital Baselland, Liestal, Switzerland; University of Basel, Liestal, Switzerland. Electronic address: paolo.spagnolo@ksbl.ch.
² Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Germany.
³ National Institute for Health Research Biological Research Unit, Royal Brompton Hospital, London, UK.

PMID: 26380887
DOI: 10.1016/S2213-2600(15)00322-7

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Enzyme Inhibitors / therapeutic use*
Humans
Idiopathic Pulmonary Fibrosis / drug therapy*
Indoles / therapeutic use
Practice Guidelines as Topic*
Pyridones / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Enzyme Inhibitors
Indoles
Pyridones
pirfenidone
nintedanib